Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-25 @ 9:21 PM
Study NCT ID:
NCT00752856
Status:
COMPLETED
Last Update Posted:
2020-07-22
First Post:
2008-09-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients
Sponsor:
University of California, San Diego
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08-26
Start Date Type:
ACTUAL
Primary Completion Date:
2011-05-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-02-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-13
First Submit QC Date:
None
Study First Post Date:
2008-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-05-14
Results First Submit QC Date:
None
Results First Post Date:
2020-07-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-13
Last Update Post Date:
2020-07-22
Last Update Post Date Type:
ACTUAL